The European Medicines Agency (EMA) is working to secure additional doses of the COVID-19 vaccine developed by Pfizer and BioNTech with an aim to deliver 1.8 billion doses to Europe by the end of 2023 ...
The AstraZeneca jab is no longer recommended for people aged under 60 after new expert immunisation panel advice.
Hosted on MSN
Mystery of rare blood clots after COVID vaccines finally solved after years-long scientific quest
After years of work, scientists have solved the mystery of an unusual side effect that impacted some recipients of the Oxford/AstraZeneca and Johnson & Johnson COVID-19 vaccines. Most importantly, the ...
The mRNA revolution didn’t end with COVID-19 – it’s only just beginning. With the MHRA’s latest guidance on personalized mRNA cancer vaccines and the world’s first RNA-based CRISPR therapy changing ...
A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering immune responses and sustaining protection, according to an analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results